The Incremental Prognostic Value of Baseline 18F‐FDG PET/CT Imaging in Angioimmunoblastic T‐Cell Lymphoma
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 4502489
Abstract
Background and Purpose. Angioimmunoblastic T‐cell lymphoma (AITL) is a rare subtype of peripheral T‐cell lymphoma with rapid disease progression and poor prognosis. The aim of this study was to determine the incremental prognostic value of baseline 18F‐fluorodeoxyglucose positron emission tomography/computed tomography (18F‐FDG PET/CT) in addition to clinical prognostic factors. Methods. From January 2010 to October 2019, a total of 23 patients who pathologically confirmed to have AITL were retrospectively analyzed. All patients underwent whole‐body 18F‐FDG PET/CT scan before chemotherapy. The 18F‐FDG PET/CT features, clinical data, laboratory indicators, Ki67 labeling index, and survival status were collected and analyzed. Results. The median follow‐up was 22 months. The expected 1‐, 2‐, and 3‐year survival rate was 72.2%, 49.6%, and 42.5%, respectively. The median overall survival (OS) was 23 months (95% confidence interval (CI): 8.459~37.541). AITL is prone to extranodal infiltration, in addition to nodal infiltration (6 patients had nodal infiltration alone, and 17 patients had both nodal and extranodal infiltration). The SUVmax of nodal lesions were higher than that for the extranodal lesions (10.43 ± 4.45, 6.64 ± 3.51, F = 2.78, t = 4.39, P < 0.01). On multivariate survival analysis, the Eastern Cooperative Oncology Group (ECOG) and SUVmax of extranodal lesions were independent predictors of OS. Conclusion. Baseline 18F‐FDG PET/CT results and SUVmax of extranodal lesions showed an incremental prognostic value in addition to clinical prognostic factors.Keywords
Funding Information
- National Natural Science Foundation of China (81971643, 81801736)
This publication has 21 references indexed in Scilit:
- Discussion of 18F-FDG PET/CT imaging characteristics and diagnostic values of angioimmunoblastic T-cell lymphomaLeukemia & Lymphoma, 2016
- Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC)European Journal of Nuclear Medicine and Molecular Imaging, 2016
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working GroupJournal of Clinical Oncology, 2014
- Spontaneous Complete Remission of Angioimmunoblastic T-Cell LymphomaBaylor University Medical Center Proceedings, 2014
- No Survival Improvement for Patients with Angioimmunoblastic T-Cell Lymphoma over the Past Two Decades: A Population-Based Study of 1207 CasesPLOS ONE, 2014
- F‐18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B‐cell lymphomaEuropean Journal of Haematology, 2014
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among ReviewersJournal of Nuclear Medicine, 2013
- Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma ProjectJournal of Clinical Oncology, 2013
- Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in JapanBlood, 2012
- Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010